Tag Archives: Formularies

April, 2015

  • 2 April

    CMS Issues Guidance on Biosimilar Reimbursement and Formulary Policies

    The Centers for Medicare & Medicaid Services (CMS) issued documents with guidance on reimbursement and formulary policies for biosimilars. The company issued documents on reimbursement of biosimilars that will remove the benefit from physicians to prescribe higher cost, branded innovator products over biosimilars. Typically, Part B physician-administered drugs are reimbursed …